The Risk for Mild Kidney Function Decline Associated with Illicit Drug Use among Hypertensive Men

American Journal of Kidney Diseases

Volumn 43, Issue 4, 2004, Pages 629-635

  Vupputuri, Suma ^a   Batuman, Vecihi ^b   Muntner, Paul ^b   Bazzano, Lydia A ^b   Lefante, John J ^b   Whelton, Paul K ^b   He, Jiang ^b  

^a IL   (United States)

^b NONE

Author keywords

Amphetamines; Chronic kidney failure; Cocaine; Cohort studies; Epidemiology; Heroin; Illicit drugs; Marijuana; Psychedelics

Indexed keywords

AMPHETAMINE; CANNABIS; COCAINE; DIAMORPHINE; PSYCHEDELIC AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ABUSE; DYSLIPIDEMIA; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LIFESTYLE; MAJOR CLINICAL STUDY; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 1642463986     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2003.12.027     Document Type: Article

References (32)

1. Substance Abuse and Mental Health Services Administration: Results From the 2001 National Household Survey on Drug Abuse: Volume I. Summary of National Findings. Rockville, MD, Office of Applied Studies, NHSDA Series H-17, DHHS publication no. SMA 02-3758, 2002
2. Dunea G, Arruda JA, Bakir AA, Share DS, Smith EC: Role of cocaine in end-stage renal disease in some hypertensive African Americans. Am J Nephrol 15:5-9, 1995
3. Brecklin CS, Gopaniuk-Folga A, Kravetz T, et al: Prevalence of hypertension in chronic cocaine users. Am J Hypertens 11:1279-1283, 1998
4. Neugarten J, Gallo GR, Buxbaum J, Katz LA, Rubenstein J, Baldwin DS: Amyloidosis in subcutaneous heroin abusers ("skin poppers' amyloidosis"). Am J Med 81:635-640, 1986
5. Tuazon CU, Hill R, Sheagren JN: Microbiologic study of street heroin and injection paraphernalia. J Infect Dis 129:327-329, 1974
6. US Renal Data System: USRDS 2002 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2002
7. Crowe AV, Howse M, Bell GM, Henry JA: Substance abuse and the kidney. QJM 93:147-152, 2000
8. Cunningham EE, Brentjens JR, Zielezny MA, Andres GA, Venuto RC: Heroin nephropathy. A clinicopathologic and epidemiologic study. Am J Med 68:47-53, 1980
9. Perneger TV, Klag MJ, Whelton PK: Recreational drug use: A neglected risk factor for end-stage renal disease. Am J Kidney Dis 38:49-56, 2001
10. Kendler KS, Jacobson KC, Prescott CA, et al: Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 160:687-695, 2003
11. Williams JB, Gibbon M, First MB, et al: The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry 49:630-636, 1992
12. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
13. Cox D: Regression models and life tables (with discussion). J R Stat Soc [B] 34:187-220, 1972
14. Di Paolo N, Fineschi V, Di Paolo M, et al: Kidney vascular damage and cocaine. Clin Nephrol 47:298-303, 1997
15. Lillie-Blanton M: Health Services Quality and Public Health Issues Health, Education, and Human Services Division: Drug Abuse: Studies Show Treatment Is Effective, But Benefits May Be Overstated. United States General Accounting Office. Testimony Before the Subcommittee on National Security, International Affairs and Criminal Justice, Committee on Government Reform and Oversight, House of Representatives, 1998
16. Brody S, Preut R: Cannabis, tobacco, and caffeine use modify the blood pressure reactivity protection of ascorbic acid. Pharmacol Biochem Behav 72:811-816, 2002
17. Jones RT: Cardiovascular system effects of marijuana. J Clin Pharmacol 42:S58-S63, 2002 (suppl 11)
18. Sidney S: Cardiovascular consequences of marijuana use. J Clin Pharmacol 42:S64-S70, 2002 (suppl 11)
19. Khalsa JH, Genser S, Francis H, Martin B: Clinical consequences of marijuana. J Clin Pharmacol 42:S7-S10, 2002 (suppl 11)
20. Zimmerman FH, Gustafson GM, Kemp HG Jr: Recurrent myocardial infarction associated with cocaine abuse in a young man with normal coronary arteries: Evidence for coronary artery spasm culminating in thrombosis. J Am Coll Cardiol 9:964-968, 1987
21. Vasica G, Tennant CC: Cocaine use and cardiovascular complications. Med J Aust 177:260-262, 2002
22. Lange RA, Hillis LD: Cardiovascular complications of cocaine use. N Engl J Med 345:351-358, 2001
23. He J, Whelton PK: Epidemiology of end-stage renal disease, in Brenner BM, Kurakawa K (eds): International Handbook of Renal Disease. Paris, France, Euromed Communications, 1999, pp 1-14
24. Ferdinand KC: Substance abuse and hypertension. J Clin Hypertens (Greenwich) 2:37-40, 2000
25. Warner EA: Cocaine abuse. Ann Intern Med 119:226-235, 1993
26. Sagar PM, Pemberton JH: Ileo-anal pouch function and dysfunction. Dig Dis 15:172-188, 1997
27. Roth D, Alarcon FJ, Fernandez JA, Preston RA, Bourgoignie JJ: Acute rhabdomyolysis associated with cocaine intoxication. N Engl J Med 319:673-677, 1988
28. Leblanc M, Hebert MJ, Mongeau JG: Cocaine-induced acute renal failure without rhabdomyolysis. Ann Intern Med 121:721-722, 1994
29. Bouget J, Bousser J, Pats B, et al: Acute renal failure following collective intoxication by Cortinarius orellanus. Intensive Care Med 16:506-510, 1990
30. Calvino J, Romero R, Pintos E, et al: Voluntary ingestion of Cortinarius mushrooms leading to chronic interstitial nephritis. Am J Nephrol 18:565-569, 1998
31. Raff E, Halloran PF, Kjellstrand CM: Renal failure after eating "magic" mushrooms. CMAJ 147:1339-1341, 1992
32. Rothman KJ, Greenland S: Modern Epidemiology. Philadelphia, PA, Lippincott-Raven, 1998